Trials in advanced Hodgkin's disease: asking the right questions at the right time

por Sweetenham, J
Publicado 2001

Leukaemia & lymphoma reviews 2

por Sweetenham, J.W.
Publicado 1994

Economics of stem cell transplantation for lymphoma: counting the cost of living

por Sweetenham, J W
Publicado 2000

Are prophylactic haematopoietic growth factors of value in the management of patients with aggressive non-Hodgkin's lymphoma?

por Hackshaw, A, Sweetenham, J, Knight, A
Publicado 2004

Model answers in ordinary national certificate mathematics for engineers

por Hilder, D W, Sweetenham, J G, Schofield, C W
Publicado 1966

Urinary epidermal growth factor (hEGF) levels in patients with carcinomas of the breast, colon and rectum.

por Sweetenham, J. W., Davies, D. E., Warnes, S., Alexander, P.
Publicado 1990

High dose intensity combination chemotherapy for advanced epithelial ovarian carcinoma: results of a pilot study.

por Sweetenham, J. W., McKendrick, J. J., Jones, D. H., Whitehouse, J. M., Williams, C. J.
Publicado 1990

The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study.

por Thompson, P., Wilson, P., Osborne, R., Slevin, M., Wiltshaw, F., Blake, P., Harper, P., Coleman, R., Williams, C., Sweetenham, J.
Publicado 1991

Involvement of the ileocaecal region by non-Hodgkin's lymphoma in adults: clinical features and results of treatment.

por Sweetenham, J. W., Mead, G. M., Wright, D. H., McKendrick, J. J., Jones, D. H., Williams, C. J., Whitehouse, J. M.
Publicado 1989